Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Contribution of Pharmaceutical Care to Person-centered Health Care and the Safety of Pharmacotherapy for Hospitalized Older Individuals in Brazil: An Investigative Single-arm Intervention Trial

Author(s): Alan Maicon de Oliveira*, Fabiana Rossi Varallo, João Paulo Vilela Rodrigues, Guilherme José Aguilar, Nereida Kilza da Costa Lima and Leonardo Régis Leira Pereira

Volume 18, Issue 2, 2023

Published on: 07 September, 2022

Page: [253 - 263] Pages: 11

DOI: 10.2174/1574886317666220614140433

Price: $65

Abstract

Background: Adverse drug events (ADE) and medication errors (ME) provide large numbers of victims. Older people are more susceptible to these events, due to the continuing search for several chronic degenerative disease treatments. The Third Global Patient Safety Challenge announced the objective of reducing unnecessary polypharmacy, encouraging deprescription, and aiming to ensure the prescription of medications in an appropriate manner, based on the best evidence and taking into account the individual factors of people.

Objective: To evaluate whether Pharmaceutical Care (PC), when inserted in a geriatric ward and the context of person-centered health care, cooperates with the safety of pharmacotherapy in older individuals in Brazil.

Methods: This is an investigative, single-arm, preliminary study. Inclusion criteria: individuals aged ≥60 years and admitted to the geriatric ward between August 2019 to January 2020. The PC (with the practice of pharmacotherapeutic follow-up, medication reconciliation, and pharmacotherapy review) was made available to identify ADE and ME, as well as the associated factors and clinical outcomes, were analyzed.

Results: 60 participants were included. It was found that, on hospital admission, 93.3% of them were polymedicated and 86.7% had a history of using potentially inappropriate medications (PIM). ADE and ME were detected in 43 individuals (71.7%) and, in total, 115 incidents were identified, with drugs that act on the nervous system associated with them (31.9%). Acceptance of the PC's recommendations reached the rate of 85.2%. Polypharmacy (p=0.03) and the presence of multiple diseases (p=0.03) had an effect on the presentation of ADE and ME. The number of medications in use decreased in the comparison between admission and hospital discharge (p<0.0001).

Conclusion: This investigative study indicated that ADE and ME are linked to the polypharmacy in use at the beginning of hospitalization. On the other hand, we showed that the PC (inserted in the multidisciplinary team) contributed to the deprescribing of medications at hospital discharge. Therefore, the PC can provide improvements in this scenario.

Keywords: Geriatrics , Patient care team , Patient-centered care , Patient safety , Pharmaceutical care , adverse drug event , medication error

« Previous Next »
Graphical Abstract

[1]
National Promotion Secretariat. Defense of Human Rights National Secretariat for the Promotion and Defense of Human Rights Data on aging in Brazil. Brasilia: Secretary National Promotion and Defense of Human Rights 2015.
[2]
Ramos LR, Garcia JT. Self-medication in elderly reidents in compinas Sao Oaulo, Brazil, Prevalence and associated factors Terapêutica medicamentosa no idoso. (23rd ed.), São Paulo: Artes Médicas 2007.
[3]
Ghibelli S, Marengoni A, Djade CD, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®)). Drugs Aging 2013; 30(10): 821-8.
[http://dx.doi.org/10.1007/s40266-013-0109-5] [PMID: 23943248]
[4]
World Health Organization. Medication safety in polypharmacy: Technical report. Geneva: World Health Organization 2019.
[5]
Munck AKR. Assessment of inappropriate medications prescribed for elderly patients in a University Hospital. HU Magazine 2014; 38(3e4)
[6]
By the 2019 American Geriatrics Society beers criteria® update expert panel. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2019; 67(4): 674-94.
[http://dx.doi.org/10.1111/jgs.15767] [PMID: 30693946]
[7]
Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005; 118(3): 251-8.
[http://dx.doi.org/10.1016/j.amjmed.2004.09.018] [PMID: 15745723]
[8]
Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M III. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care 2007; 45(5): 472-6.
[http://dx.doi.org/10.1097/01.mlr.0000254571.05722.34] [PMID: 17446834]
[9]
Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilization and costs in low- and middle-income countries. Cochrane Database Syst Rev 2013; 2: 1-69.
[10]
Pérez León M, Alonso Ramos H, González Munguía S, Marrero Penichet SM, Molero Gómez R. Evaluation of the quality of the interventions Evidence-Based Emergency Pharmacy scientific. Farm Hosp 2014; 38(2): 123-9.
[PMID: 24669897]
[11]
Mestres C, Hernandez M, Agustí A, Puerta L, Llagostera B, Amorós P. Development of a pharmaceutical care program in progressive stages in geriatric institutions. BMC Geriatr 2018; 18(1): 316.
[http://dx.doi.org/10.1186/s12877-018-1002-1] [PMID: 30567496]
[12]
Dickson D, Johnson J, Bergan R, Owens R, Subbiah V, Kurzrock R. Snapshot: Trial types in precision medicine. Cell 2020; 181(1): 208-208.e1.
[http://dx.doi.org/10.1016/j.cell.2020.02.032] [PMID: 32243791]
[13]
Watson LC, Esserman DA, Ivey JL, et al. Enhancing Quality in Psychiatry with Psychiatrists (EQUIPP)--results from a pilot study. Am J Geriatr Psychiatry 2014; 22(9): 884-8.
[http://dx.doi.org/10.1016/j.jagp.2013.01.075] [PMID: 24021216]
[14]
Schindler E, Hohmann C, Culmsee C. Medication review by community pharmacists for type 2 diabetes patients in routine care: Results of the DIATHEM-study. Front Pharmacol 2020; 11: 1176.
[http://dx.doi.org/10.3389/fphar.2020.01176] [PMID: 32903568]
[15]
Delgado Silveira E, Alvarez Díaz A, Pérez Menéndez-Conde C, Muñoz García M, Cruz-Jentoft A, Bermejo Vicedo T. Results of integrating pharmaceutical care in an acute geriatric unit. Rev Esp Geriatr Gerontol 2012; 47(2): 49-54.
[http://dx.doi.org/10.1016/j.regg.2011.11.012]
[16]
Shiwaku E, Dote S, Kaneko S, et al. Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: A prospective single-arm study. J Pharm Health Care Sci 2021; 7(1): 28.
[http://dx.doi.org/10.1186/s40780-021-00211-0] [PMID: 34334137]
[17]
Su YJ, Yan YD, Wang WJ, et al. Preliminary exploration on the role of clinical pharmacists in cancer pain pharmacotherapy. Ann Palliat Med 2020; 9(5): 3070-7.
[http://dx.doi.org/10.21037/apm-20-627] [PMID: 32787363]
[18]
Cossette B, Ricard G, Poirier R, et al. Pharmacist‐led transitions of care between hospitals, primary care clinics, and community pharmacies. J Am Geriatr Soc 2022; 70(3): 766-76.
[http://dx.doi.org/10.1111/jgs.17575] [PMID: 34817853]
[19]
Tan BK, Chua SS, Chen LC, Chang KM, Balashanker S, Bee PC. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia. J Oncol Pharm Pract 2021; 27(7): 1644-56.
[http://dx.doi.org/10.1177/1078155220964539] [PMID: 33040675]
[20]
Liu XX, Wang HX, Hu YY, et al. Drug-related problems identified by clinical pharmacists in nephrology department of a tertiary hospital in China-a single center study. Ann Palliat Med 2021; 10(8): 8701-8.
[http://dx.doi.org/10.21037/apm-21-817] [PMID: 34488359]
[21]
Resolução de Diretoria Colegiada - RDC nº 406, de 22 de julho de 2020, Dispõe sobre as Boas Práticas de Farmacovigilância para Detentores de Registro de Medicamento de uso humano, e dá outras providências. Diário Oficial da União do Brasil, nº 144, (29 de julho de 2020). [Resolution of the Collegiate Board of Directors - RDC No. 406, of July 22, 2020, Provides for Good Pharmacovigilance Practices for Holders Registration of Medicines for human use, and gives other].
[22]
Zierler-Brown S, Brown TR, Chen D, Blackburn RW. Clinical documentation for patient care: Models, concepts, and liability considerations for pharmacists. Am J Health Syst Pharm 2007; 64(17): 1851-8.
[http://dx.doi.org/10.2146/ajhp060682] [PMID: 17724368]
[23]
Sando KR, Skoy E, Bradley C, Frenzel J, Kirwin J, Urteaga E. Assessment of SOAP note evaluation tools in colleges and schools of pharmacy. Curr Pharm Teach Learn 2017; 9(4): 576-84.
[http://dx.doi.org/10.1016/j.cptl.2017.03.010] [PMID: 29233430]
[24]
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2014; 44(2): 213-8.
[http://dx.doi.org/10.1093/ageing/afu145] [PMID: 25324330]
[25]
World Health Organization, Uppsala Monitoring Centre The use of the WHO-UMC system for standardised case causality assessment. Geneva: World Health Organization 2010.
[26]
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Health Syst Pharm 1992; 49(9): 2229-32.
[http://dx.doi.org/10.1093/ajhp/49.9.2229] [PMID: 1524068]
[27]
Cortejoso L, Dietz RA, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: A prospective study in a tertiary hospital in Germany. Clin Interv Aging 2016; 11: 1343-50.
[http://dx.doi.org/10.2147/CIA.S109048] [PMID: 27713625]
[28]
Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295(7): 801-8.
[http://dx.doi.org/10.1001/jama.295.7.801] [PMID: 16478903]
[29]
Pérez-Jover V, Mira J, Carratala-Munuera C, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Environ Res Public Health 2018; 15(2): 310.
[http://dx.doi.org/10.3390/ijerph15020310] [PMID: 29439425]
[30]
Sommer J, Seeling A, Rupprecht H. Adverse drug events in patients with chronic kidney disease associated with multiple drug interactions and polypharmacy. Drugs Aging 2020; 37(5): 359-72.
[http://dx.doi.org/10.1007/s40266-020-00747-0] [PMID: 32056163]
[31]
Caçador C, Teixeira-Lemos E, Oliveira J, Pinheiro J, Teixeira-Lemos L, Ramos F. The prevalence of polypharmacy and potentially inappropriate medications and its relationship with cognitive status in portuguese institutionalized older adults: A cross-sectional study. Int J Environ Res Public Health 2022; 19(5): 2637.
[http://dx.doi.org/10.3390/ijerph19052637] [PMID: 35270323]
[32]
Ma Z, Sun S, Zhang C, et al. Characteristics of drug-related problems and pharmacists’ interventions in a geriatric unit in China. Int J Clin Pharm 2021; 43(1): 270-4.
[http://dx.doi.org/10.1007/s11096-020-01128-8] [PMID: 32860599]
[33]
Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109(2): 87-94.
[http://dx.doi.org/10.1016/S0002-9343(00)00451-4] [PMID: 10967148]
[34]
Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: Opportunities for pharmacist intervention. Int J Clin Pharm 2015; 37(2): 327-34.
[http://dx.doi.org/10.1007/s11096-014-0063-2] [PMID: 25637404]
[35]
Couto RC, Pedrosa TMG, Rosa MB. Erros acontecem: A força da transparência no enfrentamento dos eventos adversos assistenciais em pacientes hospitalizados. Belo Horizonte: Universidade Federal de Minas Gerais / Instituto de Estudos de Saúde Suplementar 2016.
[36]
Makary MA, Daniel M. Medical error—the third leading cause of death in the US. BMJ 2016; 353: i2139.
[http://dx.doi.org/10.1136/bmj.i2139] [PMID: 27143499]
[37]
Fisher E. More care is not better care. Expert Voices 2005; p. 7.
[38]
Lucchetti G, Granero AL, Pires SL, Gorzoni ML. Fatores associados à polifarmácia em idosos institucionalizados. Rev Bras Geriatr Gerontol 2010; 13(1): 51-8.
[http://dx.doi.org/10.1590/S1809-98232010000100006]
[39]
Lim W, Wong S, Leong I, Choo P, Pang W. Forging a frailty-ready healthcare system to meet population ageing. Int J Environ Res Public Health 2017; 14(12): 1448.
[http://dx.doi.org/10.3390/ijerph14121448] [PMID: 29186782]
[40]
Lee VWY, Yi PT, Kong KWY, Chan PKH, Kwok FLM. Impact of pharmacy outreach services on blood pressure management in the elderly community of Hong Kong. Geriatr Gerontol Int 2013; 13(1): 175-81.
[http://dx.doi.org/10.1111/j.1447-0594.2012.00881.x] [PMID: 22680786]
[41]
Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes 2013; 6(2): 157-63.
[http://dx.doi.org/10.1161/CIRCOUTCOMES.112.968172] [PMID: 23463811]
[42]
Law MG, Maposa P, Steeb DR, Duncan G. Addressing the global need for public health clinical pharmacists through student pharmacist education: A focus on developing nations. Int J Clin Pharm 2017; 39(6): 1141-4.
[http://dx.doi.org/10.1007/s11096-017-0537-0] [PMID: 29086146]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy